Tilray | Kortsiktig Gjeld

Current Liabilities Endring Dato
Acasti Pharma USD 1.77M 373K 2023-12
Aurora Cannabis CAD 107.38M 10.6M 2023-12
Avita Medical AUD 11.86M 3.39M 2024-03
Avrobio USD 3.51M 2.84M 2024-03
Canopy Growth CAD 234.72M 13.37M 2024-03
Cronos Group USD 33.42M 7.98M 2024-03
Dianthus Therapeutics USD 8.96M 672K 2024-03
Ionis Pharmaceuticals USD 327.65M 120.44M 2024-03
IQVIA Holdings USD 6.45B 43M 2024-03
Knight Therapeutics CAD 116.48M 2.46M 2024-03
Moderna USD 2.38B 635M 2024-03
Organigram Holdings CAD 56.03M 18.57M 2024-03
Organon & Co USD 2.55B 54M 2024-03
Revvity USD 1.37B 76.24M 2024-03
Tilray USD 329.1M 65.89M 2024-02
Viatris USD 7.76B 17.5M 2024-03
Xeris Pharmaceuticals USD 73.08M 22.11M 2024-03



Tilray Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.